BeiGene, Ltd. (NASDAQ: ONC) reported Q1 EPS of $1.22, $1.65 better than the analyst estimate of ($0.43). Revenue for the quarter came in at $1.12 billion versus the consensus estimate of $1.13 billion.

GUIDANCE:

BeiGene, Ltd. sees FY2025 revenue of $4.9-5.3 billion, versus the consensus of $5.092 billion.

For earnings history and earnings-related data on BeiGene, Ltd. (ONC) click here.